ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
BioXtek, USA
Title:Making the impossible possible, harnessing the Regenerative Power of Human Amniotic Fluid and Wharton's Jelly for Treating a Broad Spectrum of Human Pathologies
In the pursuit of longevity and enhanced quality of life, the potential of regenerative medicine is unparalleled. This presentation will explore the transformative applications of human amniotic fluid and Wharton’s Jelly in treating a wide array of human pathologies, ranging from cardiopulmonary conditions to orthopedic injuries, and from traumatic brain injuries to scar management.
Human amniotic fluid and Wharton’s Jelly are rich in growth factors, cytokines, and mesenchymal stem cells, making them powerful tools in tissue regeneration and repair. These biologically active components have shown remarkable efficacy in promoting healing, reducing inflammation, and regenerating damaged tissues.
I will discuss the emerging evidence and clinical applications of these regenerative substances in treating conditions such as pulmonary arterial hypertension, cardiac fibrosis, and traumatic brain injuries. Additionally, I will highlight their use in addressing orthopedic conditions like tennis elbow and osteoarthritis, as well as their effectiveness in improving scar outcomes.
By leveraging the innate regenerative properties of amniotic fluid and Wharton’s Jelly, we are not only addressing immediate health challenges but also contributing to the broader goal of extending human healthspan. This presentation will provide insights into the mechanisms, clinical applications, and future potential of these therapies, positioning them as key players in the field of longevity and regenerative medicine.
Join me as we delve into how these groundbreaking treatments are redefining patient care across a spectrum of conditions, offering hope for improved outcomes and enhanced quality of life.
A seasoned Entrepreneur, Physician and Researcher with over 15 years in the field of regenerative medicine. Dr. Werber is a Board-Certified reconstructive foot and ankle surgeon for over 35 years and has published several papers including submitting eight patents in placental tissues. Clinical Leadership: Dr. Werber leads our clinical initiatives, focusing on establishing the safety and efficacy of our regenerative products through rigorous research and development.